-
Loading metrics
Open Access
Peer-reviewed
Research Article
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants
-
Gavin Churchyard ,
* E-mail: GChurchyard@auruminstitute.org
Affiliations Aurum Institute for Health Research, Klerksdorp, South Africa, School of Public Health, University of Witwatersrand, Johannesburg, South Africa, Advancing Care and Treatment for TB and HIV, Medical Research Council Collaborating Centre, Klerksdorp, South Africa
⨯ -
Koleka Mlisana,
Affiliation University of Kwa-Zulu Natal, Durban, South Africa
⨯ -
Shelly Karuna,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
⨯ -
Anna-Lise Williamson,
Affiliation Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa
⨯ -
Carolyn Williamson,
Affiliation Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Services, Observatory, Cape Town, South Africa
⨯ -
Lynn Morris,
Affiliation National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa
⨯ -
Georgia D. Tomaras,
Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America
⨯ -
Stephen C. De Rosa,
Affiliations Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America
⨯ -
Peter B. Gilbert,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
⨯ -
Niya Gu,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
⨯ -
Chenchen Yu,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
⨯ -
Nonhlanhla N. Mkhize,
Affiliation National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa
⨯ -
Tandile Hermanus,
Affiliation National Institute for Communicable Diseases, National Health Laboratory Services, Sandringham, Johannesburg, South Africa
⨯ -
Mary Allen,
Affiliation Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America
⨯ -
Michael Pensiero,
Affiliation Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America
⨯ -
Susan W. Barnett,
Affiliation Novartis Vaccines and Diagnostics, Cambridge, MA, United States of America
⨯ -
Glenda Gray,
Affiliations South African Medical Research Council, Cape Town, South Africa, Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg, South Africa
⨯ -
Linda-Gail Bekker,
Affiliation Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
⨯ -
David C. Montefiori,
Affiliation Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, NC, United States of America
⨯ -
James Kublin,
Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
⨯ - [ ... ],
-
Lawrence Corey
Affiliations Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America
⨯ - [ view all ]
- [ view less ]
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants
- Gavin Churchyard,
- Koleka Mlisana,
- Shelly Karuna,
- Anna-Lise Williamson,
- Carolyn Williamson,
- Lynn Morris,
- Georgia D. Tomaras,
- Stephen C. De Rosa,
- Peter B. Gilbert,
- Niya Gu
- Published: September 1, 2016
- https://doi.org/10.1371/journal.pone.0161753